Institute of Cardiovascular Sciences and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Peking University, Beijing 100191, China.
Hebei Invivo Biotech Co., Shijiazhuang 050000, China.
Int J Mol Sci. 2019 Jul 18;20(14):3515. doi: 10.3390/ijms20143515.
Familial hypercholesterolemia (FH) is a dominant inherited disease caused mainly by low-density lipoprotein receptor (LDLR) gene mutations. To different extents, both heterozygous and homozygous FH patients develop premature coronary heart disease (CHD). However, most of the experimental animal models with LDLR deficiency could not fully recapitulate FH because they develop hyperlipidemia and atherosclerosis only in homozygous, but not in heterozygous, form. In the current study, we investigated the responsiveness of the LDLR+/- hamster to dietary cholesterol and whether plasma cholesterol levels were positively associated with the severity of atherosclerosis. Approach and Methods: wild type WT and LDLR+/- hamsters were fed a high fat diet with different cholesterol contents (HCHF) for 12 or 16 weeks. Plasma lipids, (apo)lipoproteins, and atherosclerosis in both the aorta and coronary arteries were analyzed. After a HCHF diet challenge, the levels of total cholesterol (TC) in WT and LDLR+/- hamsters were significantly elevated, but the latter showed a more pronounced lipoprotein profile, with higher cholesterol levels that were positively correlated with dietary cholesterol contents. The LDLR+/- hamsters also showed accelerated atherosclerotic lesions in the aorta and coronary arteries, whereas only mild aortic lesions were observed in WT hamsters.
Our findings demonstrate that, unlike other rodent animals, the levels of plasma cholesterol in hamsters can be significantly modulated by the intervention of dietary cholesterol, which were closely associated with severity of atherosclerosis in LDLR+/- hamsters, suggesting that the LDLR+/- hamster is an ideal animal model for FH and has great potential in the study of FH and atherosclerosis-related CHD.
家族性高胆固醇血症(FH)是一种主要由低密度脂蛋白受体(LDLR)基因突变引起的显性遗传性疾病。杂合子和纯合子 FH 患者均不同程度地发生早发冠心病(CHD)。然而,大多数 LDLR 缺陷的实验动物模型不能完全重现 FH,因为它们仅在纯合子中而不在杂合子中发展为高脂血症和动脉粥样硬化。在本研究中,我们研究了 LDLR+/-仓鼠对饮食胆固醇的反应性,以及血浆胆固醇水平是否与动脉粥样硬化的严重程度呈正相关。方法:野生型 WT 和 LDLR+/-仓鼠分别用不同胆固醇含量的高脂肪饮食(HCHF)喂养 12 或 16 周。分析血浆脂质、(载脂蛋白)脂蛋白和主动脉及冠状动脉的动脉粥样硬化。在 HCHF 饮食挑战后,WT 和 LDLR+/-仓鼠的总胆固醇(TC)水平显著升高,但后者表现出更明显的脂蛋白谱,胆固醇水平更高,与饮食胆固醇含量呈正相关。LDLR+/-仓鼠还表现出主动脉和冠状动脉粥样硬化病变的加速,而 WT 仓鼠仅观察到轻度主动脉病变。结论:我们的研究结果表明,与其他啮齿动物不同,仓鼠的血浆胆固醇水平可以通过饮食胆固醇的干预显著调节,这与 LDLR+/-仓鼠动脉粥样硬化的严重程度密切相关,表明 LDLR+/-仓鼠是 FH 的理想动物模型,在 FH 和动脉粥样硬化相关 CHD 的研究中具有巨大潜力。